AstraZeneca Earnings Hit By Higher Costs

Feb 8, 2024 | Uncategorized

AstraZeneca reported core earnings for the fourth quarter just short of consensus, but said it expected double-digit percentage growth in 2024.

Translate »
Contactar
1
Scan the code
Hola👋
¿Cómo podemos ayudarte?